# EDGAR Filing Document

**Accession Number:** 0001844280
**File Stem:** 0000950170-23-007438
**Filing Date:** 2023-3
**Character Count:** 10235
**Document Hash:** 1aa2d506fd4f2dea2ae4c41319b7716e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-23-007438.hdr.sgml**: 20230313

**ACCESSION NUMBER**: 0000950170-23-007438

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230313

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230313

**DATE AS OF CHANGE**: 20230313

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Thorne Healthtech, Inc.
- **CENTRAL INDEX KEY:** 0001844280
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 272877253
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40826
- **FILM NUMBER:** 23725704

**BUSINESS ADDRESS:**
- **STREET 1:** 620 OMNI INDUSTRIAL BLVD.
- **CITY:** SUMMERVILLE
- **STATE:** SC
- **ZIP:** 29483
- **BUSINESS PHONE:** 843-501-0286

**MAIL ADDRESS:**
- **STREET 1:** 620 OMNI INDUSTRIAL BLVD.
- **CITY:** SUMMERVILLE
- **STATE:** SC
- **ZIP:** 29483

?xml version="1.0" encoding="ASCII"? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

**FORM** 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** March 13, 2023<br>

------

Thorne HealthTech, Inc.

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 001-40826 | 27-2877253 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 152 W. 57th Street |  |  |
| New York**,** New York |  | 10019 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** (929) 251-6321<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Common Stock, $0.01 par value per share | THRN | Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

On March 13, 2023, Thorne Healthtech, Inc. (the "Company") announced that Saloni Varma, member of the Company's Board of Directors and Chair of the Audit Committee, will be appointed as the Chief Financial Officer ("CFO") of the Company, effective April 1, 2023 (the "Varma Start Date").

Ms. Varma most recently served as the CFO of MotifFoodworks, Inc., a food technology company. Prior to that, Ms. Varma was CFO of ByHeart Inc., a nutrition products company, and held various leadership roles at brands such as Chobani, Dove and Talenti, focusing on budgeting, forecasting, and execution on strategic opportunities. Ms. Varma has worked in investment banking in New York and Tokyo at UBS and began her career in accounting at KPMG. Ms. Varma holds a Masters of Commerce, Accounting from the University of Mumbai, and a Masters in Finance and Entrepreneurial Management from The Wharton School of the University of Pennsylvania. She also currently serves as the Treasurer for Common Denominator, a non-profit providing free one-on-one tutoring to children in New York City.

There are no family relationships between Ms. Varma and any director or executive officer of the Company, and she has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

Varma Employment Agreement

In connection with her appointment, the Company and Ms. Varma entered into an Employment Agreement (the "Varma Employment Agreement"), which, among other things, provides for (i) an initial base salary of $400,000, (ii) a $100,000 sign-on bonus, (iii) an annual bonus equal to a percentage of base salary, and (iv) a grant of 500,000 Restricted Stock Units.

The foregoing description of the Varma Employment Agreement is a summary and is qualified in its entirety by the terms of the Varma Employment Agreement, a copy of which will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2023.

Further information about Ms. Varma and her appointment as the CFO are included in the Company's press release issued on March 13, 2023, which is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

**Item 9.01 Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Exhibits

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibit No. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Description |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;99.1\* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<u>Press release of Thorne HealthTech, Inc., dated March 13, 2023</u>](thrn-ex99_1.htm) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;104 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cover Page Interactive Data File (embedded within the Inline XBRL document). |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\* Furnished herewith. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\* Furnished herewith. |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| Date: | March 13, 2023 | By:  | /s/ Paul Jacobson |
|  |  |  | Paul Jacobson<br>Chief Executive Officer |

---

------

## Ex-99

**Thorne HealthTech Appoints Saloni Varma as New Chief Financial Officer**

**NEW YORK (March 13, 2023)** – Thorne HealthTech, Inc. ("Thorne" or "Thorne HealthTech") (Nasdaq: THRN), a leader in developing innovative solutions for a personalized approach to health and wellness, today announced that it has appointed Saloni Varma as Chief Financial Officer ("CFO"), effective April 1, 2023.

As CFO, Ms. Varma will lead all aspects of the company's accounting and finance functions including budgeting, planning and analysis, accounting, SEC reporting, tax, treasury, and investor relations. Ms. Varma brings more than 20 years of experience across a range of consumer goods companies, most recently as CFO of MotifFoodWorks.

"Saloni brings a diverse wealth of experience to her role at Thorne and will be a key member of the leadership team," said CEO of Thorne HealthTech, Paul Jacobson. "As a member of the Board of Directors and Chair of the Audit Committee, she is already very much engrained in Thorne's strategic, operational, and manufacturing practices and has seen the continued growth over the last several years which will greatly facilitate her transition to CFO."

Ms. Varma also previously served as CFO of ByHeart, Inc., a nutrition products company, and has held various leadership roles at purpose-driven brands like Chobani, Dove, and Talenti, focusing on budgeting, forecasting, and execution on strategic opportunities. Ms. Varma has also worked in investment banking in New York and Tokyo at UBS, and she began her career in accounting at KPMG.

"As Thorne continues to make an impact as a clear leader in the health and wellness space, I look forward to working with the leadership team on creating opportunities for value creation including driving operational efficiencies, scaling the infrastructure capabilities, and executing on the company's growth strategies at a critical time when Thorne is entering its next phase of expansion," said Ms. Varma.

**About Thorne HealthTech**<br> Thorne HealthTech is a leader in developing innovative solutions for delivering personalized approaches to health and wellness. As a science-driven wellness company that empowers individuals with the support, education, and solutions they need to achieve healthy aging – living healthier longer – Thorne utilizes testing and data to create improved product efficacy and to deliver personalized solutions to consumers, health professionals, and corporations. Predicated on the power of the individual, Thorne leverages artificial intelligence models to provide insights and personalized data, products, and services that help individuals take a proactive and actionable approach to improve and maintain their health over a lifetime. Thorne is the only supplement manufacturer that collaborates with Mayo Clinic on health and wellness research and content, and is trusted by more than five million customers, 46,000+ health-care professionals, thousands of professional athletes, more than 100 professional sports teams, and multiple U.S. National Teams. For more information, visit <u>Thorne.com</u>.

**Media contact:**

<u>media@thorne.com</u>

**Investor contact:**

<u>Investors@thorne.com</u> 

------